Skip to main content
Schizophrenia Bulletin logoLink to Schizophrenia Bulletin
. 2018 Jun 23;45(2):277–283. doi: 10.1093/schbul/sby092

The Multiple Dimensions of Insight in Schizophrenia-Spectrum Disorders

Martino Belvederi Murri 1,2,3,, Mario Amore 1,2
PMCID: PMC6403083  PMID: 29939361

Abstract

The concept of insight is used to indicate the propensity of patients with schizophrenia and other severe mental disorders to recognize their illness and engage in treatment. Thus, insight may have notable consequences for the ill individual: Those who lack insight are at higher risk of nonadherence to treatments, negative clinical outcomes, and worse community functioning. Although insight is an intuitive concept, its essence remains difficult to capture. However, many rating scales are available to aid assessment, both for clinical and research purposes. Insight cannot be reduced to a symptom, a psychological mechanism, or a neuropsychological function. It is likely to have dynamic relationships with all these dimensions and with responses to personal events and contextual factors. In particular, social consequences of mental illness and explanatory models that are alternative to the medical model may fundamentally shape insight and treatment choice. Moreover, the cultural or individual stigmatization of mental illness may turn the acquisition of insight into a painful event and increase the risk of depression. Clinicians need to carefully evaluate and promote insight through a personalized approach to aid patient process of care and personal growth.

Keywords: schizophrenia, insight, stigma, depression, adherence, social cognition

What Is Insight?

In the common language, the term “insight” refers to “the capacity to gain an accurate and deep understanding of someone or something.” In the psychiatric jargon, however, the term indicates the “awareness of a mentally ill person that his/her experiences are not based on external reality.”1 In clinical practice, “insight” is used to indicate the ability of an individual to critically elaborate on his/her mental disorder and, by extension, the propensity to engage in treatment. Generally, the study of insight pertains to individuals having schizophrenia or other psychotic disorders, which are characterized by distorted contact with reality.

Although insight is a fairly intuitive concept to grasp, it eludes a precise definition. Moreover, its definition has undergone profound changes as a result of the integration of different points of view. Traditionally, the lack of insight was variously regarded as an intrinsic symptom of the disorder, a neuropsychological deficit, or a psychological defense.2 More recently, the impact of social and cultural aspects has been also acknowledged,3,4 and it has become widely accepted that insight is multi-determined.5,6 This review aims to provide a concise, nontechnical overview of the concept of insight, its development, as well as its correlates and assessment.

The ongoing debate around insight not only has theoretical implications, it is, first and foremost, of clinical utility. It is estimated that about half of patients having schizophrenia lack insight, but what are the consequences of this lack? The need to improve patient insight is widely agreed upon, but how can we achieve this goal?

Why Is Insight Important?

Insight may influence the outcomes of patients with schizophrenia and other psychoses.7 With regard to schizophrenia, individuals with lower levels of insight have a poorer prognosis in terms of quality of life, social relationships, work, or vocational outcomes across different countries.6,8–11 Intuitively this would largely depend on the refusal of treatment that leads to increased likelihood of relapses.12 However, some patients who deny their illness may nonetheless accept treatment or hospitalization. Conversely, patients with good levels of insight may not adhere to prescriptions for various reasons,13–15 including the preference for alternative care.16,17 The link between insight and adherence to antipsychotics is stronger in the months after discharge and decreases with time. Subsequently, patients may discontinue medications if they experience side effects, engage in illicit drug use, or perceive a decreased risk of relapse, regardless of insight.18 Nevertheless, insight and positive attitudes toward medications are still important factors that predict adherence to antipsychotics.18,19 Interestingly, insight may also be involved in the uptake of psychotherapy.20 Overall, it is necessary but not sufficient to ensure adherence to medications18,19 and engagement with mental health services.21

Another supposed consequence of poor insight is increased aggressive behavior. Research findings on this issue are not entirely consistent.18,22 Uncertainty may depend not only on difficulties in obtaining reliable information on violent behaviors22,23 but also on cross-cultural variations in both insight and violence.24 The link between insight and aggressive behavior seems stronger in forensic populations12 in the presence of psychopathic traits or severe positive symptoms.25

The Assessment of Insight

Many definitions of insight have been proposed, with varying degrees of complexity.5 Since the development of the Insight and Treatment Attitude Questionnaire by McEvoy et al,26 various assessment tools have been proposed accordingly, prompting evidence-based research.18

Rating scales are more frequently administered by clinicians than compiled by patients, given that the judgment of the clinician is expected to diverge from that of the patient.18 Instruments may be mono- or multi-dimensional, meaning they can rate single or multiple dimensions of insight. Table 1 reports a list of commonly used rating scales, drawn from a recent review.27 Two aspects are covered most frequently: The awareness of having a mental disorder, meaning how convinced a subject is that he/she is ill, and the recognition of treatment need. The most widely used mono-dimensional rating is the G12 item of the Positive and Negative Syndrome Scale (PANSS).28 This item, however, rates the levels of both insight and judgment. Judgment is crucial to clinical practice but not entirely pertinent to insight, making the PANSS G12 item a less specific measure. By contrast, an important ad hoc scale is the Schedule for the Assessment of Insight (SAI).29 The SAI examines (1) the ability to label certain mental events as pathological, (2) the subject’s recognition that he/she has a mental disorder, and (3) acceptance of treatment. A later expanded version also rates the awareness of adverse consequences of the illness, as well as the awareness of 4 symptoms.30 Like the SAI, the Birchwood Insight Scale31 encompasses 3 domains of insight but it is one of the few self-administered instruments available. Patients are asked if they endorse 8 statements that pertain to the awareness of the illness, the awareness of treatment need, and the relabeling of symptoms. The Scale to Assess Unawareness of Mental Disorder (SUMD), another widespread assessment tool,32 includes the following aspects, in addition to those described earlier: (1) distinct ratings for symptom awareness and attribution (the recognition of symptoms as part of an illness and the explanations on their nature, respectively), (2) several ratings of insight for individual symptoms, and (3) distinct ratings for insight of current and past symptoms.32 The SUMD prompted a comprehensive assessment of insight, but its length makes it impractical for everyday clinical use.33 Finally, research has recently seen the formulation of cognitive insight, which is assessed by the Beck Cognitive Insight Scale.34 Cognitive insight essentially refers to flexibility in thinking, which is deemed to constitute the basis of clinical insight. The lack of cognitive insight implies the inability to put experiences into perspective, overconfidence in judgments, and the inability to correct cognitive distortions with the help of others.35 Several of these scales have been translated for use in non-English-speaking populations, although precise instructions on how to deal with cultural factors are lacking.3

Table 1.

Overview of Common Tools for Assessing Insight

Instrument Domains No. of Items
PANSS item G12 (lack of judgment and insight) Unidimensional, but rating is based on (1) nonrecognition of past or present psychiatric illness or symptoms; (2) denial of need for psychiatric hospitalization or treatment; (3) decisions characterized by poor anticipation of consequences, and unrealistic short-term and long-range planning 1
ITAQ (1) Recognition of mental illness; (2) need for hospitalization; (3) need to take medications 11
SAI, SAI-E (1) Awareness and relabeling of symptoms; (2) awareness of illness; (3) treatment compliance 8 (original version), 12 (expanded version)
SUMD (1) Insight into mental disorder; (2) insight into need for treatment; (3) insight into social consequences; (4) insight into presence of symptoms; (5) insight into attribution of symptoms 74
BIS (1) Awareness of illness; (2) awareness of need for treatment; (3) relabeling of symptoms 8 (self-report)
BCIS (1) Self-reflectiveness (expression of introspection and willingness to acknowledge fallibility); (2) self-certainty (certainty about beliefs or judgments) 15 (self-report)

Note: PANSS, Positive and Negative Syndrome Scale; ITAQ, Insight and Treatment Attitudes Questionnaire; SAI-E, Schedule for the Assessment of Insight, Expanded version; SUMD, Scale to Assess Unawareness of Mental Disorder; BIS, Birchwood Insight Scale; BCIS, Beck Cognitive Insight Schedule. All instruments are intended to rate clinical insight, except for the BCIS which is intended to measure cognitive insight. For a more in-depth description, see the review by Lincoln and colleagues.18

The Elephant in the Room: Social, Cultural, and Cross-cultural Points of View

Insight and its assessment are irremediably permeated by social and cultural factors. However, lack of insight does not merely depend on insufficient education.36 Providing patients with notions on mental illness through psychoeducation may increase adherence but does not necessarily improve insight.37,38 Indeed, the understanding of an illness emerges from a complex mixture of cultural background and personal experiences, beliefs and expectations that are collectively termed “explanatory model.”3 For instance, in a landmark study explanatory models of schizophrenia held by Western-acculturated patients more often involved medical or psychosocial factors, whereas immigrants relied more frequently on spiritual factors (possession, spells) or traumatic events.39 Notably, alternative explanations do not necessarily exclude the willingness to engage in treatment11,16,40 and people (with or without psychosis) have been shown to hold different, contradictory explanatory models simultaneously.3,11,41

The evaluation of insight must also weigh the implications of mental diagnoses in the social context. Negative stereotypes of mental disorders, discrimination, and social inequity are still widespread in both high- and low-income countries.42 Stigmatization leads people to reject diagnoses and refuse treatment, even when they are aware of their symptoms.13,43,44 Even in times of easy access to information, the lay public remains generally prejudiced against individuals with psychosis, which highlights the need for strategies to reduce stigmatization.42,45,46

The cultural background of the clinician is also important in the evaluation, or rather, the “negotiation” of insight with the patient.39 Several authors contend that modern psychiatry is too heavily rooted in the medical–scientific model47 and, particularly in the “Western” world,48 psychiatrists pay insufficient attention to cultural, spiritual, and social factors.39,43,49 However, it has been argued that clinicians during their everyday clinical work may simply adopt implicit, pragmatic models that shift according to the needs of the particular consultation.50 To avoid the risk to underestimate patient insight, its assessment should be based on the individual’s cultural standards rather than on disciplinary notions.48,51,52 Particular efforts must therefore be made to facilitate communication between patients and clinicians from different cultural backgrounds.53

What Is the Time Course of Insight and Its Relationship With Psychopathology?

Insight should not be considered as a stable feature of the individual. In schizophrenia, insight seems more impaired during the first episode of illness, then improves in midlife, but declines again in older age.54 Marked variations have also been observed over shorter periods. Several patients acquire insight after the resolution of the acute psychotic phase, possibly as an effect of medications,55,56 psychosocial interventions,57 or coping with the consequences of the illness.11 Of note, improvement in insight is at least partly related to changes in symptom severity.58

Several studies have examined the relationship between insight and psychotic symptoms, particularly in schizophrenia.59 Not surprisingly, this relationship is inverse: Severe symptoms, such as delusions, are accompanied by lack of insight, or the inability to criticize such themes. The same inverse relationship has been found with regard to hallucinations, disorganization, and negative symptoms.60 However, these associations are, on the whole, weak, meaning that other factors play an important role. The only symptom dimension that correlates positively (but again, weakly) with insight is depression.27 This phenomenon has been described as the “insight paradox”: The acquisition of insight should be beneficial to the patient, but paradoxically leads to another problem. The insight paradox is often related to “post-psychotic depression,” a phase of recovery when patients develop feelings of shame and sadness as they acquire insight.61 However, insight may be associated with improved self-esteem in later periods.9 Again, it may be accompanied by demoralization and hopelessness among older patients with chronic disorders.62 Finally, the relationship between insight and depression is shaped by external factors, including the tendency to stigmatize mental illness by the patient62,63 or relatives,64,65 expectations that treatment will be ineffective, insufficient engagement with mental health services, or low socioeconomic status.66

The existence of a link with depression prompts the question of whether good insight may increase the risk of suicide. Study results have been mostly negative, but, again, there may be complex effects due to the course of the illness.67 Improvements in insight after treatment have been associated with a reduced risk of suicide, whereas subsequent reductions may have an opposite effect.68,69 Because most suicides in schizophrenia occur during the first years of illness, young patients must be carefully monitored for insight, signs of depression—particularly hopelessness70— and communications related to suicide.71 These findings suggest that the acquisition of insight is a complex and delicate process that depends on individual clinical characteristics, personal history, and environmental circumstances.37

Does Insight Depend on Neurocognitive, Metacognitive, or Social-Cognitive Abilities?

Cognitive abilities have been investigated as constituents of insight. Research suggests that insight is more specifically related to memory and executive functions, rather than to global intelligence. However, the association is of modest strength, suggesting that intact neurocognitive abilities are a precondition for insight, rather than the essence of it.72

Insight also seems to be essentially related to higher-order thinking skills, namely metacognition and social-cognition. Although the exact boundaries between these constructs are difficult to define, metacognition traditionally includes the ability to reflect on one’s own mental processes and form integrated ideas about the self, whereas social-cognition entails the mental processes underlying social relationships.6,73,74 The relevance of these dimensions is clear if we consider that insight requires the capacity to shift back and forth from one’s own perspective, to form integrated views of oneself and one’s mental processes, and to trust and accept help from others.74 Individuals who display greater metacognitive and social-cognitive abilities are more likely to give meaning to life events, including mental illness, and to construct integrated narrative accounts that form the basis of insight.74 Consistently, interventions that tackle metacognitive abilities by means of a narrative, meaning-oriented approach have shown promising results in terms of improving awareness.6,8,75,76

Other Points of View: Psychoanalysis, Phenomenology, and Neuroscience

The psychoanalytic literature has formalized the concept of defense mechanisms, which ward off painful emotions stemming from awareness. Primitive defenses, such as denial or projection, are particularly implicated in reality distortion and delusions.77 As such, lack of insight (ie, denial of the illness) would protect the individual from the painful awareness of being mentally ill. By definition these theories are difficult to test; nonetheless, a few studies have used questionnaires assessing “self-deception” to estimate the tendency to enact denial. In 1 of 2 such studies, greater self-deception was indeed associated with worse levels of insight.78,79 In other studies, the coping style termed “sealing over” has been seen to characterize the tendency of individuals with low levels of insight to repress the awareness of their psychosis or to regard it as irrelevant.80

A radically different account of insight is found in the phenomenological literature. In this view, schizophrenia is characterized by alarming and alienating self-experiences such as an abnormal sense of the body, body ownership and agency, and a primary disturbance of the structure of experience (termed “basic self-world structure”).81 Thus, psychotic experiences are indistinguishable from real ones even in the presence of evident contradictions. Therefore, insight is regarded not as a problem of self-reflection, but rather as a consequence of the altered structure of experiencing.82

Finally, research has started to unravel the neurobiological basis of insight. Several brain areas have been found to subserve insight,83 including the prefrontal and cingulate cortices, temporal and parietal lobes, the hippocampi, and cerebellum.83,84 In particular, poor insight would emerge from impaired function of self-processing areas.85 Finally, genetic research is also underway.86

Conclusions

Here, we provide a nontechnical, narrative overview on the nature, importance, and assessment of insight in schizophrenia-spectrum disorders. Insight is a key multi-determined clinical dimension, likely to influence both adherence to treatment and clinical outcomes. Although it eludes simple definitions, insight can be readily assessed with the aid of standardized rating instruments. However, particular attention must be paid to the patient’s specific cultural, social, and personal background. Nonmedical explanatory models, social disadvantage, and stigmatization may hinder the recognition of mental disorders and the acceptance of treatment. Insight generally improves as symptoms abate during treatment but may lead to depression, shame, and hopelessness. In such cases, suicidal ideas should be thoroughly investigated.71 Lack of insight has been traditionally viewed as a symptom, a cognitive deficit, or a defense mechanism, whereas modern accounts tend to point to impairments of metacognitive and social-cognitive abilities. These predisposing factors hinder patients’ ability to make sense of their illness in a structured and narrative manner. By contrast, an integrated, culturally sensitive view of insight is paramount to promote awareness and personal growth in patients with severe psychotic disorders.6,87,88

Acknowledgments

The authors would like to thank Prof. Bernard Patrick for the linguistic revision of the article. The authors have declared that there are no conflicts of interest in relation to the subject of this study.

References

  • 1. Stevenson A, ed.Oxford Dictionary of English. Oxford University Press; 2010; doi: 10.1093/acref/9780199571123.001.0001 [DOI] [Google Scholar]
  • 2. Cooke MA, Peters ER, Kuipers E, Kumari V. Disease, deficit or denial? Models of poor insight in psychosis. Acta Psychiatr Scand. 2005;112:4–17. [DOI] [PubMed] [Google Scholar]
  • 3. Jacob KS. Insight in psychosis: standards, science, ethics and value judgment. Int J Soc Psychiatry. 2017;63:345–351. [DOI] [PubMed] [Google Scholar]
  • 4. Jacob KS. The assessment of insight across cultures. Indian J Psychiatry. 2010;52:373–377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Fulford B (KWM). Insight and delusion: from Jaspers to Kraepelin and back again via Austin. In: Amador XF, David AS, eds. Insight and Psychosis: Awareness of Illness in Schizophrenia and Related Disorders. 2nd ed. New York, NY: Oxford University Press; 2004:51–78; doi: 10.1093/med/9780198525684.003.0003 [DOI] [Google Scholar]
  • 6. Lysaker PH, Pattison ML, Leonhardt BL, Phelps S, Vohs JL. Insight in schizophrenia spectrum disorders: relationship with behavior, mood and perceived quality of life, underlying causes and emerging treatments. World Psychiatry. 2018;17:12–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Drake RJ. Insight into illness: impact on diagnosis and outcome of nonaffective psychosis. Curr Psychiatry Rep. 2008;10:210–216. [DOI] [PubMed] [Google Scholar]
  • 8. Lysaker PH, Hamm JA, Hasson-Ohayon I, Pattison ML, Leonhardt BL. Promoting recovery from severe mental illness: implications from research on metacognition and metacognitive reflection and insight therapy. World J Psychiatry. 2018;8:1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Klaas HS, Clémence A, Marion-Veyron R, et al. . Insight as a social identity process in the evolution of psychosocial functioning in the early phase of psychosis. Psychol Med. 2017;47:718–729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Crumlish N, Samalani P, Sefasi A, Kinsella A, O’Callaghan E, Chilale H. Insight, psychopathology and global functioning in schizophrenia in urban Malawi. Br J Psychiatry. 2007;191:262–263. [DOI] [PubMed] [Google Scholar]
  • 11. Johnson S, Sathyaseelan M, Charles H, Jeyaseelan V, Jacob KS. Insight, psychopathology, explanatory models and outcome of schizophrenia in India: a prospective 5-year cohort study. BMC Psychiatry. 2012;12:159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Drake RJ. Insight into illness: impact on diagnosis and outcome of nonaffective psychosis. Curr Psychiatry Rep. 2008;10:210–216. [DOI] [PubMed] [Google Scholar]
  • 13. Kirmayer LJ, Corin E, Jarvis GE. Inside knowledge: cultural constructions of insight in psychosis. In: Amador XF, David AS, eds. Insight and Psychosis: Awareness of Illness in Schizophrenia and Related Disorders. 2nd ed. New York, NY: Oxford University Press; 2004:197–229. [Google Scholar]
  • 14. Linden M, Godemann F. The differentiation between ‘lack of insight’ and ‘dysfunctional health beliefs’ in schizophrenia. Psychopathology. 2007;40:236–241. [DOI] [PubMed] [Google Scholar]
  • 15. Moritz S, Favrod J, Andreou C, et al. . Beyond the usual suspects: positive attitudes towards positive symptoms is associated with medication noncompliance in psychosis. Schizophr Bull. 2013;39:917–922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Asher L, Fekadu A, Hanlon C. Global mental health and schizophrenia. Curr Opin Psychiatry. 2018;31: 193–199. [DOI] [PubMed] [Google Scholar]
  • 17. Chilale HK, Silungwe ND, Gondwe S, Masulani-Mwale C. Clients and carers perception of mental illness and factors that influence help-seeking: where they go first and why. Int J Soc Psychiatry. 2017;63:418–425. [DOI] [PubMed] [Google Scholar]
  • 18. Lincoln TM, Lüllmann E, Rief W. Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review. Schizophr Bull. 2007;33:1324–1342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Sendt KV, Tracy DK, Bhattacharyya S. A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders. Psychiatry Res. 2015;225:14–30. [DOI] [PubMed] [Google Scholar]
  • 20. Freeman D, Dunn G, Garety P, et al. . Patients’ beliefs about the causes, persistence and control of psychotic experiences predict take-up of effective cognitive behaviour therapy for psychosis. Psychol Med. 2013;43:269–277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Kvrgic S, Cavelti M, Beck EM, Rüsch N, Vauth R. Therapeutic alliance in schizophrenia: the role of recovery orientation, self-stigma, and insight. Psychiatry Res. 2013;209:15–20. [DOI] [PubMed] [Google Scholar]
  • 22. Witt K, van Dorn R, Fazel S. Risk factors for violence in psychosis: systematic review and meta-regression analysis of 110 studies. PLoS One. 2013;8:e55942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Krakowski MI, Czobor P. The denial of aggression in violent patients with schizophrenia. Schizophr Res. 2012;141:228–233. [DOI] [PubMed] [Google Scholar]
  • 24. Volavka J, Laska E, Baker S, Meisner M, Czobor P, Krivelevich I. History of violent behaviour and schizophrenia in different cultures. Analyses based on the WHO study on determinants of outcome of severe mental disorders. Br J Psychiatry. 1997;171:9–14. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med4&NEWS=N&AN=9328487 [DOI] [PubMed] [Google Scholar]
  • 25. Lincoln TM, Hodgins S. Is lack of insight associated with physically aggressive behavior among people with schizophrenia living in the community?J Nerv Ment Dis. 2008;196:62–66. [DOI] [PubMed] [Google Scholar]
  • 26. McEvoy JP, Apperson LJ, Appelbaum PS, et al. . Insight in schizophrenia. Its relationship to acute psychopathology. J Nerv Ment Dis. 1989;177:43–47. [DOI] [PubMed] [Google Scholar]
  • 27. Belvederi Murri M, Respino M, Innamorati M, et al. . Is good insight associated with depression among patients with schizophrenia? Systematic review and meta-analysis. Schizophr Res. 2015;162:234–247. [DOI] [PubMed] [Google Scholar]
  • 28. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261–276. [DOI] [PubMed] [Google Scholar]
  • 29. David AS. Insight and psychosis. Br J Psychiatry. 1990;156:798–808. [DOI] [PubMed] [Google Scholar]
  • 30. Kemp R, David A. Insight and compliance. In: Blackwell B, ed. Treatment Compliance and the Treatment Alliance in Serious Mental Illness. The Netherlands: Harwood Academic Publishers; 1997:61–84. [Google Scholar]
  • 31. Birchwood M, Smith J, Drury V, Healy J, Macmillan F, Slade M. A self-report insight scale for psychosis: reliability, validity and sensitivity to change. Acta Psychiatr Scand. 1994;89:62–67. [DOI] [PubMed] [Google Scholar]
  • 32. Amador XF, Strauss DH, Yale SA, Flaum MM, Endicott J, Gorman JM. Assessment of insight in psychosis. Am J Psychiatry. 1993;150:873–879. [DOI] [PubMed] [Google Scholar]
  • 33. Dumas R, Baumstarck K, Michel P, Lançon C, Auquier P, Boyer L. Systematic review reveals heterogeneity in the use of the scale to assess unawareness of mental disorder (SUMD). Curr Psychiatry Rep. 2013;15:361. [DOI] [PubMed] [Google Scholar]
  • 34. Beck AT, Baruch E, Balter JM, Steer RA, Warman DM. A new instrument for measuring insight: the Beck cognitive insight scale. Schizophr Res. 2004;68:319–329. [DOI] [PubMed] [Google Scholar]
  • 35. Riggs SE, Grant PM, Perivoliotis D, Beck AT. Assessment of cognitive insight: a qualitative review. Schizophr Bull. 2012;38:338–350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Wiffen BD, Rabinowitz J, Lex A, David AS. Correlates, change and “state or trait” properties of insight in schizophrenia. Schizophr Res. 2010;122:94–103. [DOI] [PubMed] [Google Scholar]
  • 37. Lysaker PH, Vohs J, Hillis JD, et al. . Poor insight into schizophrenia: contributing factors, consequences and emerging treatment approaches. Expert Rev Neurother. 2013;13:785–793. [DOI] [PubMed] [Google Scholar]
  • 38. Xia J, Merinder LB, Belgamwar MR. Psychoeducation for schizophrenia. Schizophr Bull. 2011;37:21–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Tranulis C, Corin E, Kirmayer LJ. Insight and psychosis: comparing the perspectives of patient, entourage and clinician. Int J Soc Psychiatry. 2008;54:225–241. [DOI] [PubMed] [Google Scholar]
  • 40. Berg AO, Barrett EA, Nerhus M, et al. . Psychosis: clinical insight and beliefs in immigrants in their first episode. Early Interv Psychiatry. 2015;12:185–192. [DOI] [PubMed] [Google Scholar]
  • 41. Caqueo-Urízar A, Boyer L, Baumstarck K, Gilman SE. The relationships between patients’ and caregivers’ beliefs about the causes of schizophrenia and clinical outcomes in Latin American countries. Psychiatry Res. 2015;229:440–446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Stuart H. Reducing the stigma of mental illness. Glob Ment Health (Camb). 2016;3:e17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Kim Y. Japanese attitudes towards insight in schizophrenia. In: Amador XF, David AS, (eds). Insight and Psychosis: Awareness of Illness in Schizophrenia and Related Disorders. 2nd ed. New York, NY: Oxford University Press; 2004:231–241. [Google Scholar]
  • 44. Beck EM, Cavelti M, Kvrgic S, Kleim B, Vauth R. Are we addressing the ‘right stuff’ to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication. Schizophr Res. 2011;132:42–49. [DOI] [PubMed] [Google Scholar]
  • 45. Mittal D, Sullivan G, Chekuri L, Allee E, Corrigan PW. Empirical studies of self-stigma reduction strategies: a critical review of the literature. Psychiatr Serv. 2012;63:974–981. [DOI] [PubMed] [Google Scholar]
  • 46. Wood L, Byrne R, Varese F, Morrison AP. Psychosocial interventions for internalised stigma in people with a schizophrenia-spectrum diagnosis: a systematic narrative synthesis and meta-analysis. Schizophr Res. 2016;176:291–303. [DOI] [PubMed] [Google Scholar]
  • 47. Phillips J. Conceptual models for psychiatry. Curr Opin Psychiatry. 2000;13:683–688. [Google Scholar]
  • 48. Saravanan B, David A, Bhugra D, Prince M, Jacob KS. Insight in people with psychosis: the influence of culture. Int Rev Psychiatry. 2005;17:83–87. [DOI] [PubMed] [Google Scholar]
  • 49. Saravanan B, Jacob KS, Prince M, Bhugra D, David AS. Culture and insight revisited. Br J Psychiatry. 2004;184:107–109. [DOI] [PubMed] [Google Scholar]
  • 50. Lazare A. Hidden conceptual models in clinical psychiatry. N Engl J Med. 1973;288:345–351. [DOI] [PubMed] [Google Scholar]
  • 51. Biswas J, Gangadhar BN, Keshavan M. Cross cultural variations in psychiatrists’ perception of mental illness: a tool for teaching culture in psychiatry. Asian J Psychiatr. 2016;23:1–7. [DOI] [PubMed] [Google Scholar]
  • 52. Upthegrove R, Atulomah O, Brunet K, Chawla R. Cultural and social influences of negative illness appraisals in first-episode psychosis. Early Interv Psychiatry. 2013;7:399–406. [DOI] [PubMed] [Google Scholar]
  • 53. Bhui K, Aslam RW, Palinski A, et al. . Interventions designed to improve therapeutic communications between black and minority ethnic people and professionals working in psychiatric services: a systematic review of the evidence for their effectiveness. Health Technol Assess. 2015;19:vii–xxiv, 1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Gerretsen P, Plitman E, Rajji TK, Graff-Guerrero A. The effects of aging on insight into illness in schizophrenia: a review. Int J Geriatr Psychiatry. 2014;29:1145–1161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Gerretsen P, Takeuchi H, Ozzoude M, Graff-Guerrero A, Uchida H. Insight into illness and its relationship to illness severity, cognition and estimated antipsychotic dopamine receptor occupancy in schizophrenia: an antipsychotic dose reduction study. Psychiatry Res. 2017;251:20–25. [DOI] [PubMed] [Google Scholar]
  • 56. Pijnenborg GH, Timmerman ME, Derks EM, Fleischhacker WW, Kahn RS, Aleman A. Differential effects of antipsychotic drugs on insight in first episode schizophrenia: data from the European First-Episode Schizophrenia Trial (EUFEST). Eur Neuropsychopharmacol. 2015;25:808–816. [DOI] [PubMed] [Google Scholar]
  • 57. Pijnenborg GH, van Donkersgoed RJ, David AS, Aleman A. Changes in insight during treatment for psychotic disorders: a meta-analysis. Schizophr Res. 2013;144:109–117. [DOI] [PubMed] [Google Scholar]
  • 58. Quee PJ, van der Meer L, Krabbendam L, et al. . Insight change in psychosis: relationship with neurocognition, social cognition, clinical symptoms and phase of illness. Acta Psychiatr Scand. 2014;129:126–133. [DOI] [PubMed] [Google Scholar]
  • 59. Mintz AR, Dobson KS, Romney DM. Insight in schizophrenia: a meta-analysis. Schizophr Res. 2003;61:75–88. [DOI] [PubMed] [Google Scholar]
  • 60. Xavier RM, Pan W, Dungan JR, Keefe RSE, Vorderstrasse A. Unraveling interrelationships among psychopathology symptoms, cognitive domains and insight dimensions in chronic schizophrenia. Schizophr Res. 2018;193: 83–90. [DOI] [PubMed] [Google Scholar]
  • 61. Upthegrove R, Ross K, Brunet K, McCollum R, Jones L. Depression in first episode psychosis: the role of subordination and shame. Psychiatry Res. 2014;217:177–184. [DOI] [PubMed] [Google Scholar]
  • 62. Cavelti M, Kvrgic S, Beck EM, Rüsch N, Vauth R. Self-stigma and its relationship with insight, demoralization, and clinical outcome among people with schizophrenia spectrum disorders. Compr Psychiatry. 2012;53:468–479. [DOI] [PubMed] [Google Scholar]
  • 63. Lysaker PH, Roe D, Yanos PT. Toward understanding the insight paradox: internalized stigma moderates the association between insight and social functioning, hope, and self-esteem among people with schizophrenia spectrum disorders. Schizophr Bull. 2007;33:192–199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Krupchanka D, Katliar M. The role of insight in moderating the association between depressive symptoms in people with schizophrenia and stigma among their nearest relatives: a pilot study. Schizophr Bull. 2016;42:600–607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65. Poole NA, Crabb J, Osei A, Hughes P, Young D. Insight, psychosis, and depression in Africa: a cross-sectional survey from an inpatient unit in Ghana. Transcult Psychiatry. 2013;50:433–441. [DOI] [PubMed] [Google Scholar]
  • 66. Belvederi Murri M, Amore M, Calcagno P, et al. . The “insight paradox” in schizophrenia: magnitude, moderators and mediators of the association between insight and depression. Schizophr Bull. 2016;42:1225–1233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67. López-Moríñigo JD, Ramos-Ríos R, David AS, Dutta R. Insight in schizophrenia and risk of suicide: a systematic update. Compr Psychiatry. 2012;53:313–322. [DOI] [PubMed] [Google Scholar]
  • 68. Barrett EA, Mork E, Færden A, et al. . The development of insight and its relationship with suicidality over one year follow-up in patients with first episode psychosis. Schizophr Res. 2015;162:97–102. [DOI] [PubMed] [Google Scholar]
  • 69. Bourgeois M, Swendsen J, Young F, et al. ; InterSePT Study Group. Awareness of disorder and suicide risk in the treatment of schizophrenia: results of the international suicide prevention trial. Am J Psychiatry. 2004;161: 1494–1496. [DOI] [PubMed] [Google Scholar]
  • 70. Melle I, Barrett EA. Insight and suicidal behavior in first-episode schizophrenia. Expert Rev Neurother. 2012;12: 353–359. [DOI] [PubMed] [Google Scholar]
  • 71. Pompili M, Belvederi Murri M, Patti S, et al. . The communication of suicidal intentions: a meta-analysis. Psychol Med. 2016;46:2239–2253. [DOI] [PubMed] [Google Scholar]
  • 72. Nair A, Palmer EC, Aleman A, David AS. Relationship between cognition, clinical and cognitive insight in psychotic disorders: a review and meta-analysis. Schizophr Res. 2014;152:191–200. [DOI] [PubMed] [Google Scholar]
  • 73. Lysaker PH, Vohs J, Minor KS, et al. . Metacognitive deficits in schizophrenia: presence and associations with psychosocial outcomes. J Nerv Ment Dis. 2015;203:530–536. [DOI] [PubMed] [Google Scholar]
  • 74. Vohs JL, George S, Leonhardt BL, Lysaker PH. An integrative model of the impairments in insight in schizophrenia: emerging research on causal factors and treatments. Expert Rev Neurother. 2016;16:1193–1204. [DOI] [PubMed] [Google Scholar]
  • 75. Moritz S, Mahlke CI, Westermann S, et al. . Embracing psychosis: a cognitive insight intervention improves personal narratives and meaning-making in patients with schizophrenia. Schizophr Bull. 2018;44:307–316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76. Lam KCK, Ho CPS, Wa JC, et al. . Metacognitive training (MCT) for schizophrenia improves cognitive insight: a randomized controlled trial in a Chinese sample with schizophrenia spectrum disorders. Behav Res Ther. 2015;64:38–42. [DOI] [PubMed] [Google Scholar]
  • 77. Vaillant GE. Involuntary coping mechanisms: a psychodynamic perspective. Dialogues Clin Neurosci. 2011;13:366–370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78. Moore O, Cassidy E, Carr A, O’Callaghan E. Unawareness of illness and its relationship with depression and self-deception in schizophrenia. Eur Psychiatry. 1999;14: 264–269. [DOI] [PubMed] [Google Scholar]
  • 79. Kruck CL, Flashman LA, Roth RM, Koven NS, McAllister TW, Saykin AJ. Lack of relationship between psychological denial and unawareness of illness in schizophrenia-spectrum disorders. Psychiatry Res. 2009;169:33–38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80. McGlashan TH, Docherty JP, Siris S. Integrative and sealing-over recoveries from schizophrenia: distinguishing case studies. Psychiatry. 1976;39:325–338. [DOI] [PubMed] [Google Scholar]
  • 81. Hur JW, Kwon JS, Lee TY, Park S. The crisis of minimal self-awareness in schizophrenia: a meta-analytic review. Schizophr Res. 2014;152:58–64. [DOI] [PubMed] [Google Scholar]
  • 82. Henriksen MG, Parnas J. Self-disorders and schizophrenia: a phenomenological reappraisal of poor insight and noncompliance. Schizophr Bull. 2014;40:542–547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83. Xavier RM, Vorderstrasse A. Neurobiological basis of insight in schizophrenia: a systematic review. Nurs Res. 2016;65:224–237. [DOI] [PubMed] [Google Scholar]
  • 84. Sapara A, Ffytche DH, Birchwood M, et al. . Preservation and compensation: the functional neuroanatomy of insight and working memory in schizophrenia. Schizophr Res. 2014;152:201–209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85. Ćurčić-Blake B, van der Meer L, Pijnenborg GH, David AS, Aleman A. Insight and psychosis: functional and anatomical brain connectivity and self-reflection in Schizophrenia. Hum Brain Mapp. 2015;36:4859–4868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86. Xavier RM, Vorderstrasse A, Keefe RSE, Dungan JR. Genetic correlates of insight in schizophrenia. Schizophr Res. 2018;195:290–297. [DOI] [PubMed] [Google Scholar]
  • 87. Vohs JL, Leonhardt BL, James AV, et al. . Metacognitive reflection and insight therapy for early psychosis: a preliminary study of a novel integrative psychotherapy. Schizophr Res. 2018;195:428–433. [DOI] [PubMed] [Google Scholar]
  • 88. Jørgensen R, Licht RW, Lysaker PH, et al. . Effects on cognitive and clinical insight with the use of guided self-determination in outpatients with schizophrenia: a randomized open trial. Eur Psychiatry. 2015;30:655–663. [DOI] [PubMed] [Google Scholar]

Articles from Schizophrenia Bulletin are provided here courtesy of Oxford University Press

RESOURCES